NeurogesX, Inc.

NeurogesX, Inc., a biopharmaceutical company, focuses on developing and commercializing pain management therapies. Its lead product includes Qutenza (capsaicin) 8% patch, a non-narcotic analgesic formulated dermal delivery system containing an 8% concentration of synthetic capsaicin.

Ticker:
NGSX
Exchange:
NASDAQ (See More NASDAQ Companies)
Sector:
Healthcare (See More Healthcare Companies)